173 related articles for article (PubMed ID: 35269556)
1. Overexpression of miR-375 and L-type Amino Acid Transporter 1 in Pheochromocytoma and Their Molecular and Functional Implications.
Manso J; Bertazza L; Barollo S; Mondin A; Censi S; Carducci S; Ferrara AM; Boschin IM; Zovato S; Schiavi F; Gregianin M; Pennelli G; Iacobone M; Mian C
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269556
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of L-Type Amino Acid Transporter 1 (LAT1) and 2 (LAT2): Novel Markers of Neuroendocrine Tumors.
Barollo S; Bertazza L; Watutantrige-Fernando S; Censi S; Cavedon E; Galuppini F; Pennelli G; Fassina A; Citton M; Rubin B; Pezzani R; Benna C; Opocher G; Iacobone M; Mian C
PLoS One; 2016; 11(5):e0156044. PubMed ID: 27224648
[TBL] [Abstract][Full Text] [Related]
3.
Feral CC; Tissot FS; Tosello L; Fakhry N; Sebag F; Pacak K; Taïeb D
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):812-821. PubMed ID: 27900521
[TBL] [Abstract][Full Text] [Related]
4. Correlation of the genotype of paragangliomas and pheochromocytomas with their metabolic phenotype on 3,4-dihydroxy-6-18F-fluoro-L-phenylalanin PET.
Rischke HC; Benz MR; Wild D; Mix M; Dumont RA; Campbell D; Seufert J; Wiech T; Rössler J; Weber WA; Neumann HP
J Nucl Med; 2012 Sep; 53(9):1352-8. PubMed ID: 22836345
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of 18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma.
Luster M; Karges W; Zeich K; Pauls S; Verburg FA; Dralle H; Glatting G; Buck AK; Solbach C; Neumaier B; Reske SN; Mottaghy FM
Eur J Nucl Med Mol Imaging; 2010 Mar; 37(3):484-93. PubMed ID: 19862519
[TBL] [Abstract][Full Text] [Related]
6.
Kroiss AS; Uprimny C; Shulkin BL; Gruber L; Frech A; Jazbec T; Girod PP; Url C; Thomé C; Riechelmann H; Sprinzl GM; Fraedrich G; Virgolini IJ
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):94-99. PubMed ID: 30630744
[TBL] [Abstract][Full Text] [Related]
7. Transport of 3-fluoro-L-α-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET.
Wiriyasermkul P; Nagamori S; Tominaga H; Oriuchi N; Kaira K; Nakao H; Kitashoji T; Ohgaki R; Tanaka H; Endou H; Endo K; Sakurai H; Kanai Y
J Nucl Med; 2012 Aug; 53(8):1253-61. PubMed ID: 22743251
[TBL] [Abstract][Full Text] [Related]
8. The role of LAT1 in (18)F-DOPA uptake in malignant gliomas.
Youland RS; Kitange GJ; Peterson TE; Pafundi DH; Ramiscal JA; Pokorny JL; Giannini C; Laack NN; Parney IF; Lowe VJ; Brinkmann DH; Sarkaria JN
J Neurooncol; 2013 Jan; 111(1):11-8. PubMed ID: 23086431
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of [18F]-DA and [18F]-DOPA for PET imaging in a mouse model of pheochromocytoma.
Martiniova L; Cleary S; Lai EW; Kiesewetter DO; Seidel J; Dawson LF; Phillips JK; Thomasson D; Chen X; Eisenhofer G; Powers JF; Kvetnansky R; Pacak K
Nucl Med Biol; 2012 Feb; 39(2):215-26. PubMed ID: 21958851
[TBL] [Abstract][Full Text] [Related]
10. PET Imaging of L-Type Amino Acid Transporter (LAT1) and Cystine-Glutamate Antiporter (x
Krys D; Mattingly S; Glubrecht D; Wuest M; Wuest F
Mol Imaging Biol; 2020 Dec; 22(6):1562-1571. PubMed ID: 32789819
[TBL] [Abstract][Full Text] [Related]
11. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
[TBL] [Abstract][Full Text] [Related]
12. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
[TBL] [Abstract][Full Text] [Related]
13. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDOPA PET/CT Imaging of MAX-Related Pheochromocytoma.
Taïeb D; Jha A; Guerin C; Pang Y; Adams KT; Chen CC; Romanet P; Roche P; Essamet W; Ling A; Quezado MM; Castinetti F; Sebag F; Pacak K
J Clin Endocrinol Metab; 2018 Apr; 103(4):1574-1582. PubMed ID: 29534198
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma.
Timmers HJ; Chen CC; Carrasquillo JA; Whatley M; Ling A; Havekes B; Eisenhofer G; Martiniova L; Adams KT; Pacak K
J Clin Endocrinol Metab; 2009 Dec; 94(12):4757-67. PubMed ID: 19864450
[TBL] [Abstract][Full Text] [Related]
16. The effects of carbidopa on uptake of 6-18F-Fluoro-L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma.
Timmers HJ; Hadi M; Carrasquillo JA; Chen CC; Martiniova L; Whatley M; Ling A; Eisenhofer G; Adams KT; Pacak K
J Nucl Med; 2007 Oct; 48(10):1599-606. PubMed ID: 17873132
[TBL] [Abstract][Full Text] [Related]
17. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
Grassi I; Nanni C; Vicennati V; Castellucci P; Allegri V; Montini GC; Pagotto U; di Dalmazi G; Pasquali R; Fanti S
Clin Nucl Med; 2011 Feb; 36(2):124-6. PubMed ID: 21220975
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis of pheochromocytoma with special emphasis on MEN2 syndrome.
Pacak K; Eisenhofer G; Ilias I
Hormones (Athens); 2009; 8(2):111-6. PubMed ID: 19570738
[TBL] [Abstract][Full Text] [Related]
19. L-type amino acid transporters LAT1 and LAT4 in cancer: uptake of 3-O-methyl-6-18F-fluoro-L-dopa in human adenocarcinoma and squamous cell carcinoma in vitro and in vivo.
Haase C; Bergmann R; Fuechtner F; Hoepping A; Pietzsch J
J Nucl Med; 2007 Dec; 48(12):2063-71. PubMed ID: 18056335
[TBL] [Abstract][Full Text] [Related]
20. 18F-FDOPA PET/CT Uptake Parameters Correlate with Catecholamine Secretion in Human Pheochromocytomas.
Moog S; Houy S; Chevalier E; Ory S; Weryha G; Rame M; Klein M; Brunaud L; Gasman S; Cuny T
Neuroendocrinology; 2018; 107(3):228-236. PubMed ID: 29949805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
